Arenas, V.;                     Castaño, J.L.;                     DomÃnguez, J.J.;                     Yáñez, L.;                     Pipaón, C.    
        Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers 2025, 17, 533.
    https://doi.org/10.3390/cancers17030533
    AMA Style
    
                                Arenas V,                                 Castaño JL,                                 DomÃnguez JJ,                                 Yáñez L,                                 Pipaón C.        
                Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers. 2025; 17(3):533.
        https://doi.org/10.3390/cancers17030533
    
    Chicago/Turabian Style
    
                                Arenas, VÃctor,                                 Jose Luis Castaño,                                 Juan José DomÃnguez,                                 Lucrecia Yáñez,                                 and Carlos Pipaón.        
                2025. "Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo" Cancers 17, no. 3: 533.
        https://doi.org/10.3390/cancers17030533
    
    APA Style
    
                                Arenas, V.,                                 Castaño, J. L.,                                 DomÃnguez, J. J.,                                 Yáñez, L.,                                 & Pipaón, C.        
        
        (2025). Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers, 17(3), 533.
        https://doi.org/10.3390/cancers17030533